QR Code

Targeting Investigation and Treatment in Type 2 Myocardial Infarction

Background: Type 2 myocardial infarction occurs in the absence of atherothrombosis, due to myocardial oxygen supply or demand imbalance, often during another acute illness. It is common and associated with poor clinical outcomes. No randomized controlled trials are available to guide investigation o...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Caelan Taggart, MD, Amy Ferry, BSc, Stephanie Barker, BSc, Kelly Williams, BSc, Grace Souter, BSc, Anda Bularga, MD, Ryan Wereski, MD, Michael J. McDermott, MD, Michelle C. Williams, MD, PhD, Jasper Boeddinghaus, MD, Christopher White, BSc, Jagdeep S. Singh, MD, Keith Boath, BSc, Takeshi Fujisawa, PhD, Christopher Tuck, MSc, Anny Briola, MSc, Steff Lewis, PhD, Atul Anand, MD, PhD, Marc R. Dweck, MD, PhD, David E. Newby, MD, DSc, Rustam Al-Shahi Salman, MD, PhD, Nicholas L. Mills, MD, PhD, Andrew R. Chapman, MD, PhD
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2025-05-01
Rangatū:JACC: Advances
Ngā marau:
coronary angiography
echocardiography
secondary prevention
type 2 myocardial infarction
universal definition
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2772963X25001553
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite